Serum HER-2/NEU decline predicts improved response to trastuzumab-based therapy (serum HER-2/NEU study group) Meeting Abstract


Authors: Ali, S. M.; Esteva, F. J.; Fornier, M.; Harris, L.; Köstler, W. J.; Lotz, J. P.; Luftner, D.; Pichon, M. F.; Tse, C.; Lipton, A.
Abstract Title: Serum HER-2/NEU decline predicts improved response to trastuzumab-based therapy (serum HER-2/NEU study group)
Meeting Title: 31th ESMO Congress
Journal Title: Annals of Oncology
Volume: 17
Issue: Suppl. 9
Meeting Dates: 2006 Sep 29-Oct 3
Meeting Location: Istanbul, Turkey
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2006-09-01
Start Page: ix69
Language: English
ACCESSION: WOS:000248078900150
PROVIDER: wos
PUBMED: 17018761
DOI: 10.1093/annonc/mdl205
Notes: Meeting Abstract: 139O - 31th Congress of the European-Society-for-Medical-Oncology - SEP 29-OCT 03, 2006 - Istanbul, TURKEY - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Nancy Fornier
    158 Fornier